ARCHIVES

In Phase II Study, Vaccine IMA910 Stimulated Immune Response

This article is from The Cancer Letter archive.

Vol. 35 No. 2 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

December 27, 2002

In Brief: Anti-Smoking Resolution Lost In White House; Pay Bill Defeat Leaves 73 At The Top In NCI

March 22, 1974

Bishop: Cells, Genes Reveal Unified Strategy For Cancer Conquest

March 3, 1995

60 Minutes Report “Deception at Duke” Wins Peabody Award

March 29, 2013

In Brief: Panel to Meet Jan. 30 In Los Angeles; Fate Of Proposed Urologic Group Depends On Budget

January 10, 1986

CMS Proposes To End Automatic Coverage Of Clinical Trials For Medicare Patients.

October 12, 2007